Form 4: Abbott VP & Controller Sells Shares

Abbott Laboratories' Vice President and Controller, John A. McCoy, Jr., reported the sale of common shares for tax withholding and personal liquidity.

Summary

• John A. McCoy, Jr., Vice President and Controller of Abbott Laboratories (ABT), filed a Form 4 detailing recent share transactions.
• On February 27, 2026, McCoy disposed of 1,142 common shares at a price of $116.26 per share. This transaction was identified as a tax withholding event (Transaction Code F).
• On March 2, 2026, McCoy sold an additional 585 common shares at a price of $115.58 per share (Transaction Code S).
• Following these reported transactions, McCoy directly holds 24,628 common shares.
• Additionally, McCoy indirectly holds 58 common shares through the Abbott Laboratories Stock Retirement Trust as of February 27, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it involves insider selling, one transaction is for tax withholding, and the other is a relatively small sale, common for personal financial management.

Negatives

• Insider selling, even for tax purposes or personal liquidity, can sometimes be perceived negatively by the market, though these are relatively small amounts.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, particularly for tax-related purposes (Code F), is a common occurrence and typically does not signal a change in company fundamentals. The additional sale (Code S) is also relatively small in the context of the executive's total holdings and the company's market capitalization, suggesting it's likely for personal financial planning rather than a bearish signal on Abbott's prospects.

Stakeholder Impact

• Shareholders may note the insider selling, but given the nature and size of the transactions, the direct impact is likely minimal.

Key Dates

Recommendation

The reported insider transactions are routine and do not provide a strong signal for a change in investment recommendation. One transaction is for tax withholding, and the other is a relatively small sale, likely for personal liquidity, rather than a reflection of a negative outlook on the company's fundamentals. Investors should continue to hold based on broader company performance and market conditions.

Keywords

Abbott Laboratories, ABT, Insider Trading, Form 4, Share Sale, Executive Compensation, John A. McCoy Jr.